Avant Diagnostics Commences OvaDx Ovarian Cancer Test Calibration in Preparation for FDA Submission
September 24, 2015 at 10:26 AM EDT
Avant Diagnostics, Inc. (OTC: AVDX) began calibration testing in preparation for the validation study of OvaDx®, which will be used to ...